Provided by Tiger Trade Technology Pte. Ltd.

Caris Life Sciences, Inc.

28.30
-0.0500-0.18%
Post-market: 28.300.00000.00%16:01 EDT
Volume:3.14M
Turnover:89.10M
Market Cap:7.98B
PE:76.08
High:28.97
Open:28.72
Low:28.07
Close:28.35
52wk High:33.66
52wk Low:14.19
Shares:282.15M
Float Shares:116.00M
Volume Ratio:0.88
T/O Rate:2.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3720
EPS(LYR):-3.2200
ROE:20.13%
ROA:8.77%
PB:13.49
PE(LYR):-8.79

Loading ...

Caris studies MSH3 loss impact on immune checkpoint outcomes across cancers at ASCO 2026

Reuters
·
May 22

Cloud AI Update - CAI Boosts Multicloud Integration With AWS And Microsoft Partnerships

Simply Wall St.
·
May 22

CAI Corp Reports Unaudited Net Asset Value of HK$0.14 Per Share

TIPRANKS
·
May 15

Analysts Are Bullish on These Healthcare Stocks: Crispr Therapeutics AG (CRSP), Caris Life Sciences, Inc. (CAI)

TIPRANKS
·
May 14

Caris Life Sciences Director Makes Bold Insider Move With Major Stock Purchase

TIPRANKS
·
May 13

Stock Track | Caris Life Sciences Soars 5.08% Intraday on Director Share Purchase and Analyst Rating

Stock Track
·
May 12

Caris director Jeff L Vacirca acquires 31,050 shares for $501,426.95

Reuters
·
May 12

Caris Life Sciences, Inc. (CAI) Gets a Hold from Piper Sandler

TIPRANKS
·
May 12

Caris Life Sciences announces publication of study on measuring TMB using WES

TIPRANKS
·
May 12

Caris study finds whole exome TMB predicts pembrolizumab survival better than gene panels

Reuters
·
May 12

Guggenheim Sticks to Their Buy Rating for Caris Life Sciences, Inc. (CAI)

TIPRANKS
·
May 11

Caris Life Sciences submits application to NYSDOH for Caris Assure testing

TIPRANKS
·
May 09

Caris Life Sciences Submits Application for Molecular Profiling Test in New York State

MT Newswires Live
·
May 09

Caris Life Sciences Submits Application to New York State Department of Health for Caris Assure Blood‑Based Testing Authorization

THOMSON REUTERS
·
May 09

Caris submits NY health department review application for Caris Assure blood test authorization

Reuters
·
May 09

Stock Track | Caris Life Sciences Plummets 15.32% Intraday Despite Earnings Beat on Quarterly Loss and Analyst Estimate Revisions

Stock Track
·
May 08

Caris Life Sciences, Inc. (CAI) Gets a Hold from Piper Sandler

TIPRANKS
·
May 08

Guggenheim Sticks to Its Buy Rating for Caris Life Sciences, Inc. (CAI)

TIPRANKS
·
May 08

Caris Life Sciences price target lowered to $28 from $35 at Citi

TIPRANKS
·
May 08

Caris Life Sciences Is Maintained at Buy by BTIG

Dow Jones
·
May 08